November 11-12, 2021
Online Livestream
2nd Rx to OTCSymposium
Leverage Novel Digital Tools, Telemedicine and eCommerce Breakthroughs to Maximize Success at Launch
Days
Hours
Minutes
Seconds
Rx to OTC switches become even more important in the current era where responsibility for healthcare is being assigned to consumers. In new scenarios where consumers are making important decisions about their care, we must first improve the problems of access to and costs of medicines. Increasing the availability of appropriate over the counter medicines helps ease the burdens of cost and access.
The strategy and execution of a successful Rx to OTC switch requires assurance that consumers can self-diagnose, self-treat and self-manage on their own and that the drug has low potential for misuse and abuse. Demonstrating that a medicine should switch from prescription to over the counter requires the help of a cross functional team including regulatory, clinical, and marketing. DGE’s Rx to OTC Switch Symposium provides an excellent opportunity to bring your team together to talk about the latest challenges and opportunities in switches including human factor studies to help prevent misuse of products, digital tools to enable switching in more difficult categories, and the impact of increasing use of telemedicine on the potential for a switch.
Top Reasons to Attend
- Gain an update on DTC companies causing a barrier to traditional switch and the current consumer landscape
- Take a deep dive into strategies for commercializing switches and retail execution
- Identify the pathway moving forward from the FDA and regulatory approaches
- Obtain an update on digital initiatives to aid more complex switches
- Determine how to manage COVID related regulatory and clinical delays
Agenda at a Glance
Topics covered will include:
- Conduct human factors studies to help prevent misuse of a product and improve packaging
- Use digital tools including medical devices and apps to accompany more complex products
- Determine whether telemedicine will slow or quicken future switches
- Highlight the current landscape and areas most currently active for switch candidates
- Work cross functionally to develop claims and bring science to life
Who Should Attend
This conference is designed for pharmaceutical, biotech, and medical device professionals responsible for:
- Rx-to-OTC Switch/Rx Access
- Regulatory Affairs
- Brand Management
- Product Management
- Brand Marketing
- Legal Affairs
- Digital
- Medical/Scientific Affairs
- Consumer Healthcare Products
- Consumer Marketing
- Clinical Development
- Clinical Trial
- Drug Safety
- Research and Development
- Business Strategy
- Packaging & Labeling
- Drug Delivery Technology
- Product Development
- Portfolio Strategy
- Project Management
Conference Association Partners
Conference Pricing
15
Speakers
21
Days
251
Participants
125
Workshops
90
Venue
Contact Us
Stay Connected Subscribe
Stay up to date on the latest announcements